Insider Transactions in Q4 2022 at Theseus Pharmaceuticals, Inc. (THRX)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2022
|
Donald J Hayden Jr Director |
BUY
Open market or private purchase
|
Direct |
9,900
+49.75%
|
$49,500
$5.0 P/Share
|
|
Dec 29
2022
|
Foresite Capital Management V, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
500,000
+11.83%
|
$2,500,000
$5.0 P/Share
|
|
Dec 29
2022
|
Donald J Hayden Jr Director |
BUY
Open market or private purchase
|
Direct |
100
+50.0%
|
$500
$5.0 P/Share
|
|
Nov 30
2022
|
Bradford D. Dahms President and CFO |
BUY
Open market or private purchase
|
Direct |
1,502
+19.65%
|
$9,012
$6.66 P/Share
|
|
Nov 11
2022
|
Timothy P Clackson President and CEO |
BUY
Open market or private purchase
|
Direct |
2,500
+0.71%
|
$15,000
$6.8 P/Share
|
|
Nov 07
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
192,000
+1.13%
|
$960,000
$5.21 P/Share
|
|
Nov 07
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
192,000
+1.13%
|
$960,000
$5.21 P/Share
|